By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ProteoTech Inc 

12040 115th Ave NE

Kirkland  Washington  98034  U.S.A.
Phone: n/a Fax: n/a


Key Statistics

Ownership: Private

Web Site: ProteoTech


Company News
ProteoTech Presents Update On Its New Product "Cognitive Claritytm" At The 12th International Conference On Alzheimer’s And Parkinson’s Diseases In Nice, France, March 18–22, 2015 3/27/2015 11:17:13 AM
ProteoTech Is Granted Orphan Drug Designation For Systebryl™ (PTI-110) For The Treatment Of AL Amyloidosis 1/12/2015 11:17:00 AM
ProteoTech Appoints Dr. Roger Flugel As Chief Executive Officer 1/12/2015 10:32:50 AM
ProteoTech To Present At The Alzheimer's Association International Conference (AAIC)®, Copenhagen, Denmark, July 12-17, 2014 7/16/2014 9:10:13 AM
ProteoTech Selected to Present at Cavendish Global Health Impact Forum 5/2/2014 9:49:28 AM
Dr. Alan Snow From ProteoTech To Present At The XIV International Symposium On Amyloidosis 4/30/2014 9:22:19 AM
ProteoTech's Chief Scientific Officer, Dr. Alan Snow, to Present New Data on "SystebrylTM for the Treatment of Systemic AA Amyloidosis" at the XIIIth International Symposium on Amyloidosis, Groningen, Netherlands, May 6-10, 2012 4/23/2012 11:22:13 AM
ProteoTech and GlaxoSmithKline (GSK) (China) Collaborate on Parkinson's Drug Candidate 1/3/2012 2:49:21 PM
ProteoTech Announces Drug Development Collaborative Agreement with GlaxoSmithKline (GSK) for New Parkinson's Therapeutic 12/20/2011 7:06:42 AM
ProteoTech and Tasly Pharmaceutical Announce Alzheimer's Disease Drug Development Agreement for Exebryl-1(R) 10/4/2010 11:35:30 AM